Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Gastrointestinal hormones

Uroguanylin—a new gut-derived weapon against obesity?

A recent report has identified uroguanylin as an endocrine signal that exerts a physiological role in energy homeostasis, adding another factor to the gut–brain axis. From a clinical point of view, several observations highlight the uroguanylin–guanylyl cyclase C pathway as a potential therapeutic target for the development of antiobesity drugs.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1

References

  1. Potter, L. R. Regulation and therapeutic targeting of peptide-activated receptor guanylyl cyclases. Pharmacol. Ther. 130, 71–82 (2011).

    Article  CAS  PubMed  Google Scholar 

  2. Valentino, M. A. et al. A uroguanylin–GUCY2C endocrine axis regulates feeding in mice. J. Clin. Invest. 121, 3578–3588 (2011).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Lorenz, J. N. et al. Uroguanylin knockout mice have increased blood pressure and impaired natriuretic response to enteral NaCl load. J. Clin. Invest. 112, 1244–1254 (2003).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Lin, J. E. et al. The hormone receptor GUCY2C suppresses intestinal tumor formation by inhibiting AKT signaling. Gastroenterology 138, 241–254 (2010).

    Article  CAS  PubMed  Google Scholar 

  5. Steinbrecher, K. A. et al. Murine guanylate cyclase C regulates colonic injury and inflammation. J. Immunol. 186, 7205–7214 (2011).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Flemström, G., Bengtsson, M. W., Mäkelä, K. & Herzig, K. H. Effects of short-term food deprivation on orexin-A-induced intestinal bicarbonate secretion in comparison with related secretagogues. Acta Physiol. (Oxf.) 198, 373–380 (2010).

    Article  Google Scholar 

  7. Kokrashvili, Z. et al. Release of endogenous opioids from duodenal enteroendocrine cells requires Trpm5. Gastroenterology 137, 598–606 (2009).

    Article  PubMed  PubMed Central  Google Scholar 

  8. Liedtke, W. B. et al. Relation of addiction genes to hypothalamic gene changes subserving genesis and gratification of a classic instinct, sodium appetite. Proc. Natl Acad. Sci. USA 108, 12509–12514 (2011).

    Article  CAS  PubMed  Google Scholar 

  9. Gong, R. et al. Role for the membrane receptor guanylyl cyclase-C in attention deficiency and hyperactive behavior. Science 333, 1642–1646 (2011).

    Article  CAS  PubMed  Google Scholar 

  10. Munger, S. D. et al. An olfactory subsystem that detects carbon disulfide and mediates food-related social learning. Curr. Biol. 20, 1438–1444 (2010).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Frühbeck, G. Uroguanylin—a new gut-derived weapon against obesity?. Nat Rev Endocrinol 8, 5–6 (2012). https://doi.org/10.1038/nrendo.2011.206

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrendo.2011.206

This article is cited by

Search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research